Potential for Larger Gene Panels to Increase the Number of Molecularly Matched Therapies in Patients with Advanced Solid Tumours By Ogkologos - April 22, 2025 716 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ProfiLER-02 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer October 22, 2021 EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab April 28, 2021 Neighborhood Celebrates Teen’s Last Chemo Session With Socially-Distanced Parade March 27, 2020 FDA Grants Accelerated Approval to the Combination of Avutometinib and Defactinib... May 30, 2025 Load more HOT NEWS News digest – naked mole-rats, junk food deals, ovarian cancer drug... Easing Concerns about Giving Research Study Participants Their Genetic Test Results 27-Year-Old Thought She Was Injured Falling Off A Horse, But Then... EMA Recommends Extension of Indications for Alectinib to Adjuvant Treatment of...
